Bruce Booth
Director, Zafgen (United States).
Companies
- Sionna Therapeutics, Inc.Board member Feb 6, 2025 to now1
- Vigil Neuroscience, Inc.Board member Jan 6, 2022 to now2
- Kymera TherapeuticsBoard member Aug 20, 2020 to now3
- Tectonic Therapeutic, Inc.Board member Jun 20, 2018 to Jun 8, 20234
- Magenta TherapeuticsBoard member Jun 20, 2018 to Jun 30, 20225
- Cogent Biosciences, Inc.Board member Mar 28, 2018 to Jul 6, 20206
- Viridian Therapeutics, Inc.\DEBoard member Feb 13, 2017 to Jun 28, 20187
- Zafgen (United States)Board member Jun 18, 2014 to Jan 5, 20188
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kymera Therapeutics KYMR462,856 shares9$50.1M at $108.14Jun 29, 2026
- Sionna Therapeutics, Inc. SION686,567 shares10$2.8M at $4.11Oct 21, 2025
- Vigil Neuroscience, Inc.0 shares11Aug 5, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 29, 2026Sold 3,024 shares at $107.76 of Kymera Therapeutics12
- Jun 29, 2026Sold 2,318 shares at $106.63 of Kymera Therapeutics12
- Jun 29, 2026Sold 848 shares at $105.78 of Kymera Therapeutics12
- Jun 29, 2026Sold 19,093 shares at $107.76 of Kymera Therapeutics12
- Jun 29, 2026Sold 14,613 shares at $106.63 of Kymera Therapeutics12
- Jun 29, 2026Sold 5,471 shares at $105.78 of Kymera Therapeutics12
- Jun 29, 2026Sold 130 shares at $111.20 of Kymera Therapeutics9
- Jun 29, 2026Sold 1,078 shares at $110.67 of Kymera Therapeutics9
- Jun 29, 2026Sold 1,104 shares at $109.75 of Kymera Therapeutics9
- Jun 29, 2026Sold 1,498 shares at $108.28 of Kymera Therapeutics9
- Jun 29, 2026Sold 2,698 shares at $107.76 of Kymera Therapeutics9
- Jun 29, 2026Sold 2,133 shares at $106.63 of Kymera Therapeutics9
- Jun 29, 2026Sold 157 shares at $111.20 of Kymera Therapeutics13
- Jun 29, 2026Sold 770 shares at $105.78 of Kymera Therapeutics9
- Jun 29, 2026Sold 1,199 shares at $110.67 of Kymera Therapeutics13
- Jun 29, 2026Sold 934 shares at $111.20 of Kymera Therapeutics9
- Jun 29, 2026Sold 1,239 shares at $109.75 of Kymera Therapeutics13
- Jun 29, 2026Sold 7,723 shares at $110.67 of Kymera Therapeutics9
- Jun 29, 2026Sold 1,688 shares at $108.28 of Kymera Therapeutics13
- Jun 29, 2026Sold 7,968 shares at $109.75 of Kymera Therapeutics9
- Jun 29, 2026Sold 907 shares at $111.20 of Kymera Therapeutics13
- Jun 29, 2026Sold 10,848 shares at $108.28 of Kymera Therapeutics9
- Jun 29, 2026Sold 7,602 shares at $110.67 of Kymera Therapeutics13
- Jun 29, 2026Sold 19,419 shares at $107.76 of Kymera Therapeutics9
- Jun 29, 2026Sold 7,833 shares at $109.75 of Kymera Therapeutics13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARKymera Therapeutics, Board member
- 4
- 5SEC EDGARMagenta Therapeutics, Board member
- 6
- 7
- 8SEC EDGARZafgen (United States), Board member
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Jun 30, 2026
- 13SEC EDGARForm 4 filed Jun 30, 2026